×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.

Become an Incathlab member and receive full access to its content!

You must be an Incathlab member to access videos without any restrictions. Register for free in one minute and access all services provided by Incathlab.You will also be able to log into Incathlab from your Facebook or twitter account by clicking on login on the top-right corner of Incathlab website.

Registration Login


  • 65 ans - Référé pour tachycardie ventriculaire avec multiples chocs par défibrillateur
  • Patient asymptomatique mais 3 épisodes de chocs électriques sur TV probable
  • ATCD médicaux
    • Cardiomyopathie ischémique – SCA (2004) avec dysfonction VG sévère
    • Resynchronisation / implantation BiV + défibrillateur
    • Remplacement boitier 2012
    • FA chronique anticoagulée
    • Dyslipidémie, tabagisme ancien
    • IRC modérée
    • HypoT4
  • Échographie cardiaque (03/2018)
    • FeVG 30-35%, DTDVG 69 mm, akinésie inféro-latérale, IM 2/4, dilatation bi-auriculaire, PAP normale
  • ECG repos
    • Fibrillation auriculaire, rythme électro-entrainé
  • Biologie
    • Hb 16.0 g/l, Plt 239.000, créat 17.4 mg/l (ClCr 41 ml/min), ProBNP 2511 pg/ml, Tropo -
  • Traitement médical
    • Kardegic 75 mg OD, amiodarone 200 mg OD, ramipril 5 mg BID, furosémide 250 mg BID, bisoprolol 5 mg BID, Previscan, Pravastatine 20 mg OD, Aldactone 25 mg OD, Diffu K, Levothyroxine, Pantoprazole
Shooting date : 2018-04-12
Last update : 2018-05-28

Suggestions

Thursday, October 9th 2025 from 12pm to 01pm (GMT+2)
Honolulu : Thursday, October 9th 2025 from 01am to 02am (GMT+2)
San Francisco : Thursday, October 9th 2025 from 04am to 05am (GMT+2)
New York : Thursday, October 9th 2025 from 07am to 08am (GMT+2)
Buenos Aires : Thursday, October 9th 2025 from 08am to 09am (GMT+2)
Reykjavik : Thursday, October 9th 2025 from 11am to 12pm (GMT+2)
London / Dublin : Thursday, October 9th 2025 from 12pm to 01pm (GMT+2)
Paris / Berlin : Thursday, October 9th 2025 from 01pm to 02pm (GMT+2)
Istanbul : Thursday, October 9th 2025 from 02pm to 03pm (GMT+2)
Moscou / Dubaï : Thursday, October 9th 2025 from 03pm to 04pm (GMT+2)
Bangkok : Thursday, October 9th 2025 from 06pm to 07pm (GMT+2)
Shanghai : Thursday, October 9th 2025 from 07pm to 08pm (GMT+2)
Tokyo : Thursday, October 9th 2025 from 08pm to 09pm (GMT+2)
Sydney : Thursday, October 9th 2025 from 10pm to 11pm (GMT+2)
Wellington : Friday, October 10th 2025 from 12am to 01am (GMT+2)

RMS Freesolve:

Continuing the Journey and Discovering the Potential of Scaffolds

Share
Monday, October 30th 2023 from 05pm to 06pm (GMT+1)
Honolulu : Monday, October 30th 2023 from 06am to 07am (GMT+1)
San Francisco : Monday, October 30th 2023 from 08am to 09am (GMT+1)
New York : Monday, October 30th 2023 from 11am to 12pm (GMT+1)
Buenos Aires : Monday, October 30th 2023 from 01pm to 02pm (GMT+1)
London / Dublin : Monday, October 30th 2023 from 04pm to 05pm (GMT+1)
Paris / Berlin : Monday, October 30th 2023 from 05pm to 06pm (GMT+1)
Istanbul : Monday, October 30th 2023 from 06pm to 07pm (GMT+1)
Moscou / Dubaï : Monday, October 30th 2023 from 08pm to 09pm (GMT+1)
Bangkok : Monday, October 30th 2023 from 11pm to 12am (GMT+1)
Shanghai : Tuesday, October 31st 2023 from 12am to 01am (GMT+1)
Tokyo : Tuesday, October 31st 2023 from 01am to 02am (GMT+1)
Sydney : Tuesday, October 31st 2023 from 02am to 03am (GMT+1)
Wellington : Tuesday, October 31st 2023 from 04am to 05am (GMT+1)

How do the new antithrombotic recommendations affect your HBR patients?

Gain insights from a patient case analysis

Share
Scroll Up